|
|
Volumn 34, Issue 11, 1998, Pages 943-956
|
|
Mode of action and adverse effects of lipid lowering drugs
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACIPIMOX;
ANTILIPEMIC AGENT;
BEZAFIBRATE;
CHYLOMICRON;
CLOFIBRATE;
COLESTIPOL;
COLESTYRAMINE;
COPOLYMER;
FIBRIC ACID DERIVATIVE;
GEMFIBROZIL;
HIGH DENSITY LIPOPROTEIN;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
INTERMEDIATE DENSITY LIPOPROTEIN;
LIPOPROTEIN;
LOW DENSITY LIPOPROTEIN;
MEVINOLIN;
NICERITROL;
NICOTINIC ACID;
NICOTINIC ACID DERIVATIVE;
PRAVASTATIN;
PROBUCOL;
SIMVASTATIN;
VERY LOW DENSITY LIPOPROTEIN;
CHOLESTEROL BLOOD LEVEL;
CLINICAL FEATURE;
COMBINATION CHEMOTHERAPY;
COST BENEFIT ANALYSIS;
DISEASE ASSOCIATION;
DRUG COST;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG MECHANISM;
DRUG SAFETY;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
HYPERLIPIDEMIA;
MYOPATHY;
MYOSITIS;
ORAL DRUG ADMINISTRATION;
PATHOPHYSIOLOGY;
PRURITUS;
REVIEW;
|
|
EID: 0032469693
PISSN: 16993993
EISSN: 16994019
Source Type: Journal
DOI: 10.1358/dot.1998.34.11.487479 Document Type: Review |
|
Times cited : (31)
|
|
References (76)
|
